Jaw clenching after sugammadex for muscle relaxation reversal
Treatments studied
Part of Brain & nervous system clinical trials.
This trial tests whether a drug called sugammadex, which reverses muscle relaxation from anesthesia, might cause jaw clenching in some people. The study will watch for this effect during routine surgery to better understand the risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 19 and 70 years old.
- You are scheduled for elective (non-emergency) surgery under general anesthesia.
- You will receive a muscle relaxant called rocuronium during anesthesia.
- You do not have any muscle or nerve disorders.
- Your kidneys are working well (no kidney disease or dialysis).
- You have no history of jaw clenching, teeth grinding, or dental problems.
- You are not allergic to the study drugs (sugammadex or rocuronium).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a drug called sugammadex that helps you wake up faster and breathe better after weight-loss surgery. It may help you recover more quickly and safely after your operation.
This trial tests two medicines that help reverse the muscle-relaxing drugs given to patients on breathing tubes in the intensive care unit. The goal is to see which one works better and faster so patients can wake up sooner.
This study tests a domestic version of sugammadex sodium (a drug that reverses muscle relaxants) after lung surgery. It aims to see how well it works to help you wake up and recover from anesthesia.
This trial tests a drug called sugammadex, which is used to reverse the effects of a muscle relaxant given during anesthesia. It is for adults having general or brain surgery, and aims to help you wake up and breathe more quickly after surgery.
This trial compares two medications given to reverse the effects of muscle relaxants after an outpatient ERCP (a scope procedure). The goal is to see which drug works better and faster, which could help you wake up more comfortably.
This study tests different doses of a medicine called sugammadex to reverse the effects of a muscle relaxant (rocuronium) used during surgery in infants under 24 months old. It aims to find the best dose to help babies recover from anesthesia safely and quickly.
Hear when a new Sugammadex trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.